Literature DB >> 11704588

Inflammatory response and body composition in chronic obstructive pulmonary disease.

A A Eid1, A A Ionescu, L S Nixon, V Lewis-Jenkins, S B Matthews, T L Griffiths, D J Shale.   

Abstract

Weight loss in chronic obstructive airways disease (COPD) is associated with an increased energy cost of breathing. To determine an association between body composition and the inflammatory response we studied 80 clinically stable patients. Body composition was determined anthropometrically and skeletal muscle mass was determined as the creatinine-height index (CHI). Forty patients had their nitrogen balance determined. Circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and their soluble receptors were determined for 68 patients. Body mass index (BMI) was normal (> 20 kg/m(2)) in 55 patients, of whom 17 (31%) had a low CHI (< 80% predicted). A reduced CHI was associated with increased circulating levels of IL-6 (p = 0.001), TNF-alpha (p = 0.032) and their soluble receptors IL-6sr (p = 0.002), TNF-alpha sr1 (p = 0.03), and TNF-alpha sr2 (p = 0.001). Patients with a normal BMI and low CHI had inflammatory mediator levels similar to patients with a low BMI and CHI; both were significantly greater than in those with a normal BMI and CHI. Nitrogen balance was similar between normal and low CHI groups, although nitrogen excretion was significantly increased in the low CHI group. Skeletal muscle loss in COPD is probably multifactorial in origin, but our data suggest a link with systemic inflammation, even when weight loss is inapparent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704588     DOI: 10.1164/ajrccm.164.8.2008109

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  76 in total

Review 1.  [Comorbidities of COPD].

Authors:  H Watz; H Magnussen
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

2.  Systemic inflammation and progression of COPD.

Authors:  Jørgen Vestbo
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

3.  Sarcopaenia in chronic obstructive pulmonary disease.

Authors:  Michael C Steiner
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

Review 4.  Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Omar A Minai; Zab Mosenifar
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

5.  Therapeutic Treatment with Abdominal Adipose Mesenchymal Cells Does Not Prevent Elastase-Induced Emphysema in Rats.

Authors:  Pınar Yıldız Gülhan; Mehmet Savaş Ekici; Mehmet Niyaz; Muhammet Gülhan; Mustafa Emre Erçin; Aydanur Ekici; Nurkan Aksoy
Journal:  Turk Thorac J       Date:  2020-01-01

Review 6.  Chronic obstructive pulmonary disease and obstructive sleep apnoea-the overlap syndrome.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

7.  Altered tissue distribution in adults with cystic fibrosis.

Authors:  C E Bolton; A A Ionescu; W D Evans; R J Pettit; D J Shale
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

8.  Patterns of Body Composition Relating to Chronic Respiratory Diseases Among Adults in Four Resource-Poor Settings in Peru.

Authors:  Grace Trompeter; Matthew R Grigsby; Catherine H Miele; Robert A Wise; Robert H Gilman; J Jaime Miranda; Antonio Bernabe-Ortiz; William Checkley
Journal:  Lung       Date:  2018-03-20       Impact factor: 2.584

9.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

10.  Association of bone mineral density with airway obstruction and emphysema.

Authors:  Yun Su Sim; Jin Hwa Lee; Yookyung Kim; Jung Hyun Chang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.